This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cesca Therapeutics (NASDAQ:KOOL)CurrentInstitutional OwnershipPercentage3.11%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$403.31KNumber ofInstitutional Sellers(last 12 months)0 Get KOOL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cesca Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Cesca Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2025OLD Mission Capital LLC33,937$350K0.0%N/A1.405% 4/14/2025Farther Finance Advisors LLC5,405$56K0.0%N/A0.224% (Data available from 1/1/2016 forward) KOOL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KOOL shares? During the previous two years, the following institutional investors and hedge funds held shares of Cesca Therapeutics shares: OLD Mission Capital LLC ($350K), Farther Finance Advisors LLC ($56K).Learn more on Cesca Therapeutics' institutional investors. What percentage of Cesca Therapeutics' stock is owned by institutional investors? 3.11% of Cesca Therapeutics' stock is owned by institutional investors. Learn more on KOOL's institutional investor holdings. Which institutional investors have been buying Cesca Therapeutics' stock? The following institutional investors have purchased Cesca Therapeutics' stock in the last 24 months: OLD Mission Capital LLC ($33.94K), and Farther Finance Advisors LLC ($5.41K). How much institutional buying is happening at Cesca Therapeutics? Institutional investors have bought a total of 39,342 shares in the last 24 months. This purchase volume represents approximately $403.31K in transactions. Related Companies TARA Major Shareholders ZNTL Major Shareholders BHST Major Shareholders PDEX Major Shareholders SEER Major Shareholders ADAG Major Shareholders SPRO Major Shareholders QIPT Major Shareholders RCEL Major Shareholders EQ Major Shareholders This page (NASDAQ:KOOL) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KOOL Stock Alerts